// App-Quantinova.ai

1538 : Vimentin expression as a potential immunomarker of predicting aggressive disease in clear cell renal cell carcinoma

Researchers

Presenter

  • Mahmoud Mohamed

Principal Investigators

  • Lulin Hu

  • Haiyan Liu

  • Fan Lin

  • Heinric Williams

Medical Centers

  • Geisinger Health System, Danville, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Clear cell renal carcinoma

  • Gastric Cancer

  • Renal cell carcinoma

  • Prostate cancer

  • Lung Cancer

  • Solid malignancies

  • Melanoma

Biomarkers

  • Vimentin

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A